The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Etanercept-Global Market Insights and Sales Trends 2024
Synopsis
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis.
The global Etanercept market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Etanercept in various end use industries. The expanding demands from the Arthritis, Psoriasis, Spondylitis and Others, are propelling Etanercept market. Benepali, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enbrel segment is estimated at % CAGR for the next seven-year period.
The production of TNF in the body causes inflammation, pain, and damage to the bones and joints. Etanercept blocks the action of TNF and reduces the inflammation. It is prescribed to treat juvenile rheumatoid arthritis, rheumatoid arthritis, and psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Etanercept, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Etanercept market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Etanercept market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Etanercept sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Etanercept covered in this report include Amgen, Pfizer, Takeda, Sanofi, GlaxoSmithKline, Sandoz, Celltrion, Dexa Medica and Bionovis, etc.
The global Etanercept market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Pfizer
Takeda
Sanofi
GlaxoSmithKline
Sandoz
Celltrion
Dexa Medica
Bionovis
Momenta Pharmaceuticals
HanAll Biopharma
MedImmune
Tsumura
Global Etanercept market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Etanercept market, Segment by Type:
Benepali
Enbrel
Others
Global Etanercept market, by Application
Arthritis
Psoriasis
Spondylitis
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Etanercept manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Etanercept in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis.
The global Etanercept market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Etanercept in various end use industries. The expanding demands from the Arthritis, Psoriasis, Spondylitis and Others, are propelling Etanercept market. Benepali, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enbrel segment is estimated at % CAGR for the next seven-year period.
The production of TNF in the body causes inflammation, pain, and damage to the bones and joints. Etanercept blocks the action of TNF and reduces the inflammation. It is prescribed to treat juvenile rheumatoid arthritis, rheumatoid arthritis, and psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Etanercept, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Etanercept market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Etanercept market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Etanercept sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Etanercept covered in this report include Amgen, Pfizer, Takeda, Sanofi, GlaxoSmithKline, Sandoz, Celltrion, Dexa Medica and Bionovis, etc.
The global Etanercept market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Pfizer
Takeda
Sanofi
GlaxoSmithKline
Sandoz
Celltrion
Dexa Medica
Bionovis
Momenta Pharmaceuticals
HanAll Biopharma
MedImmune
Tsumura
Global Etanercept market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Etanercept market, Segment by Type:
Benepali
Enbrel
Others
Global Etanercept market, by Application
Arthritis
Psoriasis
Spondylitis
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Etanercept manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Etanercept in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Etanercept Market Overview
1.1 Etanercept Product Overview
1.2 Etanercept Market Segment by Type
1.2.1 Benepali
1.2.2 Enbrel
1.2.3 Others
1.3 Global Etanercept Market Size by Type
1.3.1 Global Etanercept Market Size Overview by Type (2018-2029)
1.3.2 Global Etanercept Historic Market Size Review by Type (2018-2023)
1.3.3 Global Etanercept Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Etanercept Sales Breakdown by Type (2018-2023)
1.4.2 Europe Etanercept Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Etanercept Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Etanercept Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Etanercept Sales Breakdown by Type (2018-2023)
2 Global Etanercept Market Competition by Company
2.1 Global Top Players by Etanercept Sales (2018-2023)
2.2 Global Top Players by Etanercept Revenue (2018-2023)
2.3 Global Top Players by Etanercept Price (2018-2023)
2.4 Global Top Manufacturers Etanercept Manufacturing Base Distribution, Sales Area, Product Type
2.5 Etanercept Market Competitive Situation and Trends
2.5.1 Etanercept Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Etanercept Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Etanercept as of 2022)
2.7 Date of Key Manufacturers Enter into Etanercept Market
2.8 Key Manufacturers Etanercept Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Etanercept Status and Outlook by Region
3.1 Global Etanercept Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Etanercept Historic Market Size by Region
3.2.1 Global Etanercept Sales in Volume by Region (2018-2023)
3.2.2 Global Etanercept Sales in Value by Region (2018-2023)
3.2.3 Global Etanercept Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Etanercept Forecasted Market Size by Region
3.3.1 Global Etanercept Sales in Volume by Region (2024-2029)
3.3.2 Global Etanercept Sales in Value by Region (2024-2029)
3.3.3 Global Etanercept Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Etanercept by Application
4.1 Etanercept Market Segment by Application
4.1.1 Arthritis
4.1.2 Psoriasis
4.1.3 Spondylitis
4.1.4 Others
4.2 Global Etanercept Market Size by Application
4.2.1 Global Etanercept Market Size Overview by Application (2018-2029)
4.2.2 Global Etanercept Historic Market Size Review by Application (2018-2023)
4.2.3 Global Etanercept Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Etanercept Sales Breakdown by Application (2018-2023)
4.3.2 Europe Etanercept Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Etanercept Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Etanercept Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Etanercept Sales Breakdown by Application (2018-2023)
5 North America Etanercept by Country
5.1 North America Etanercept Historic Market Size by Country
5.1.1 North America Etanercept Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Etanercept Sales in Volume by Country (2018-2023)
5.1.3 North America Etanercept Sales in Value by Country (2018-2023)
5.2 North America Etanercept Forecasted Market Size by Country
5.2.1 North America Etanercept Sales in Volume by Country (2024-2029)
5.2.2 North America Etanercept Sales in Value by Country (2024-2029)
6 Europe Etanercept by Country
6.1 Europe Etanercept Historic Market Size by Country
6.1.1 Europe Etanercept Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Etanercept Sales in Volume by Country (2018-2023)
6.1.3 Europe Etanercept Sales in Value by Country (2018-2023)
6.2 Europe Etanercept Forecasted Market Size by Country
6.2.1 Europe Etanercept Sales in Volume by Country (2024-2029)
6.2.2 Europe Etanercept Sales in Value by Country (2024-2029)
7 Asia-Pacific Etanercept by Region
7.1 Asia-Pacific Etanercept Historic Market Size by Region
7.1.1 Asia-Pacific Etanercept Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Etanercept Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Etanercept Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Etanercept Forecasted Market Size by Region
7.2.1 Asia-Pacific Etanercept Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Etanercept Sales in Value by Region (2024-2029)
8 Latin America Etanercept by Country
8.1 Latin America Etanercept Historic Market Size by Country
8.1.1 Latin America Etanercept Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Etanercept Sales in Volume by Country (2018-2023)
8.1.3 Latin America Etanercept Sales in Value by Country (2018-2023)
8.2 Latin America Etanercept Forecasted Market Size by Country
8.2.1 Latin America Etanercept Sales in Volume by Country (2024-2029)
8.2.2 Latin America Etanercept Sales in Value by Country (2024-2029)
9 Middle East and Africa Etanercept by Country
9.1 Middle East and Africa Etanercept Historic Market Size by Country
9.1.1 Middle East and Africa Etanercept Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Etanercept Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Etanercept Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Etanercept Forecasted Market Size by Country
9.2.1 Middle East and Africa Etanercept Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Etanercept Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Amgen Etanercept Products Offered
10.1.5 Amgen Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Etanercept Products Offered
10.2.5 Pfizer Recent Development
10.3 Takeda
10.3.1 Takeda Company Information
10.3.2 Takeda Introduction and Business Overview
10.3.3 Takeda Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Takeda Etanercept Products Offered
10.3.5 Takeda Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Etanercept Products Offered
10.4.5 Sanofi Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKline Etanercept Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Sandoz
10.6.1 Sandoz Company Information
10.6.2 Sandoz Introduction and Business Overview
10.6.3 Sandoz Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sandoz Etanercept Products Offered
10.6.5 Sandoz Recent Development
10.7 Celltrion
10.7.1 Celltrion Company Information
10.7.2 Celltrion Introduction and Business Overview
10.7.3 Celltrion Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Celltrion Etanercept Products Offered
10.7.5 Celltrion Recent Development
10.8 Dexa Medica
10.8.1 Dexa Medica Company Information
10.8.2 Dexa Medica Introduction and Business Overview
10.8.3 Dexa Medica Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Dexa Medica Etanercept Products Offered
10.8.5 Dexa Medica Recent Development
10.9 Bionovis
10.9.1 Bionovis Company Information
10.9.2 Bionovis Introduction and Business Overview
10.9.3 Bionovis Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bionovis Etanercept Products Offered
10.9.5 Bionovis Recent Development
10.10 Momenta Pharmaceuticals
10.10.1 Momenta Pharmaceuticals Company Information
10.10.2 Momenta Pharmaceuticals Introduction and Business Overview
10.10.3 Momenta Pharmaceuticals Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Momenta Pharmaceuticals Etanercept Products Offered
10.10.5 Momenta Pharmaceuticals Recent Development
10.11 HanAll Biopharma
10.11.1 HanAll Biopharma Company Information
10.11.2 HanAll Biopharma Introduction and Business Overview
10.11.3 HanAll Biopharma Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.11.4 HanAll Biopharma Etanercept Products Offered
10.11.5 HanAll Biopharma Recent Development
10.12 MedImmune
10.12.1 MedImmune Company Information
10.12.2 MedImmune Introduction and Business Overview
10.12.3 MedImmune Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.12.4 MedImmune Etanercept Products Offered
10.12.5 MedImmune Recent Development
10.13 Tsumura
10.13.1 Tsumura Company Information
10.13.2 Tsumura Introduction and Business Overview
10.13.3 Tsumura Etanercept Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Tsumura Etanercept Products Offered
10.13.5 Tsumura Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Etanercept Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Etanercept Industrial Chain Analysis
11.4 Etanercept Market Dynamics
11.4.1 Etanercept Industry Trends
11.4.2 Etanercept Market Drivers
11.4.3 Etanercept Market Challenges
11.4.4 Etanercept Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Etanercept Distributors
12.3 Etanercept Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
